Ginseng-plus-Bai-Hu-Tang ameliorates diet-induced obesity, hepatic steatosis, and insulin resistance in mice |
Lu, Hsu-Feng
(Departments of Clinical Pathology, Cheng Hsin General Hospital)
Lai, Yu-Heng (Department of Chemistry, Chinese Culture University) Huang, Hsiu-Chen (Department of Applied Science, National Tsing Hua University South Campus) Lee, I-Jung (Department of Kampo Medicine, Yokohama University of Pharmacy) Lin, Lie-Chwen (National Research Institute of Chinese Medicine, Ministry of Health and Welfare) Liu, Hui-Kang (National Research Institute of Chinese Medicine, Ministry of Health and Welfare) Tien, Hsiao-Hsuan (Department of Biotechnology and Laboratory Science in Medicine, National Yang-Ming University) Huang, Cheng (Department of Biotechnology and Laboratory Science in Medicine, National Yang-Ming University) |
1 | Morimoto A, et al. Increase in homeostasis model assessment of insulin resistance (HOMA-IR) had a strong impact on the development of type 2 diabetes in Japanese individuals with impaired insulin secretion: the Saku study. PLoS One 2014;9(8):e105827. DOI |
2 | Pataky MW, et al. High-fat diet-induced insulin resistance in single skeletal muscle fibers is fiber type selective. Sci Rep 2017;7(1):13642. DOI |
3 | Hancock CR, et al. High-fat diets cause insulin resistance despite an increase in muscle mitochondria. Proc Natl Acad Sci U S A 2008;105(22):7815-20. DOI |
4 | Xiong, Y., et al., Antiobesity and antihyperglycemic effects of ginsenoside Rb1 in rats. Diabetes. 59(10): p. 2505-2512. DOI |
5 | Dunn W, et al. Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. Am J Gastroenterol 2008;103(9):2263-71. DOI |
6 | Regev A, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002;97(10):2614-8. DOI |
7 | Cheng J, et al. Loss of Mbd2 protects mice against high-fat diet-induced obesity and insulin resistance by regulating the homeostasis of energy storage and expenditure. Diabetes 2016;65(11):3384-95. DOI |
8 | Enomoto H, et al. Liver fibrosis markers of nonalcoholic steatohepatitis. World J Gastroenterol 2015;21(24):7427-35. DOI |
9 | Armutcu F, et al. Markers in nonalcoholic steatohepatitis. Adv Clin Chem 2013;61:67-125. DOI |
10 | Sharma S, Khalili K, Nguyen GC. Non-invasive diagnosis of advanced fibrosis and cirrhosis. World J Gastroenterol 2014;20(45):16820-30. DOI |
11 | Smith, B.W. and L.A. Adams, Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment. Nat Rev Endocrinol. 7(8): p. 456-465. DOI |
12 | Lam B, Younossi ZM. Treatment options for nonalcoholic fatty liver disease. Therap Adv Gastroenterol 2010;3(2):121-37. DOI |
13 | Postic C, Girard J. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest 2008;118(3):829-38. DOI |
14 | Masuoka, H.C. and N. Chalasani, Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals. Ann N Y Acad Sci. 1281: p. 106-122. DOI |
15 | Adams LA, Angulo P. Treatment of non-alcoholic fatty liver disease. Postgrad Med J 2006;82(967):315-22. DOI |
16 | Nobili V, et al. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial. Hepatology 2008;48(1):119-28. DOI |
17 | Chen CC, et al. Peroxisome proliferator-activated receptor gamma transactivation-mediated potentiation of glucose uptake by Bai-Hu-Tang. J Ethnopharmacol 2008;118(1):46-50. DOI |
18 | Huang CY, et al. Prescription pattern of Chinese herbal products for diabetes mellitus in taiwan: a population-based study. Evid Based Complement Alternat Med 2013;2013:201329. |
19 | Podrini C, et al. High-fat feeding rapidly induces obesity and lipid derangements in C57BL/6N mice. Mamm Genome 2013;24(5-6):240-51. DOI |
20 | Johnson RJ, et al. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am J Clin Nutr 2007;86(4):899-906. |
21 | Fraulob JC, et al. A mouse model of metabolic syndrome: insulin resistance, fatty liver and non-alcoholic fatty pancreas disease (NAFPD) in C57BL/6 mice fed a high fat diet. J Clin Biochem Nutr 2010;46(3):212-23. DOI |
22 | Suliga E, et al. Factors associated with adiposity, lipid profile disorders and the metabolic syndrome occurrence in premenopausal and postmenopausal women. PLoS One 2016;11(4):e0154511. DOI |
23 | Kimura I, et al. The antihyperglycaemic blend effect of traditional Chinese medicine byakko-ka-ninjin-to on alloxan and diabetic KK-CA(y) mice. Phytother Res 1999;13(6):484-8. DOI |
24 | Liu HK, et al. Ginseng-plus-Bai-Hu-Tang decoction reduces fatty liver by activating AMP-activated protein kinase in vitro and in vivo. Evid Base Compl Alternat Med 2015;2015:651734. |
25 | Kawamoto TH, et al. Resting metabolic rates of two orbweb spiders: a first approach to evolutionary success of ecribellate spiders. J Insect Physiol 2011;57(3):427-32. DOI |
26 | Zambo, V., et al., Lipotoxicity in the liver. World J Hepatol. 5(10): p. 550-557. DOI |
27 | Fabbrini E, Magkos F. Hepatic steatosis as a marker of metabolic dysfunction. Nutrients 2015;7(6):4995-5019. DOI |
28 | Cassidy WM, Reynolds TB. Serum lactic dehydrogenase in the differential diagnosis of acute hepatocellular injury. J Clin Gastroenterol 1994;19(2):118-21. DOI |
29 | Dufour DR, et al. Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Clin Chem 2000;46(12):2050-68. DOI |
30 | Giordano C, et al. Uric acid as a marker of kidney disease: review of the current literature. Dis Markers 2015;2015:382918. DOI |
31 | Yuan G, Al-Shali KZ, Hegele RA. Hypertriglyceridemia: its etiology, effects and treatment. CMAJ 2007;176(8):1113-20. DOI |
32 | Sato A, et al. Antiobesity effect of eicosapentaenoic acid in high-fat/highsucrose diet-induced obesity: importance of hepatic lipogenesis. Diabetes 2010;59(10):2495-504. DOI |
33 | Ling JC, et al. Determinants of high fasting insulin and insulin resistance among overweight/obese adolescents. Sci Rep 2016;6:36270. DOI |
34 | Park S, et al. Ginsenosides Rb1 and Rg1 suppress triglyceride accumulation in 3T3-L1 adipocytes and enhance beta-cell insulin secretion and viability in Min6 cells via PKA-dependent pathways. Biosci Biotechnol Biochem 2008;72(11):2815-23. DOI |
35 | Shen, L., et al., Ginsenoside Rb1 reduces fatty liver by activating AMPactivated protein kinase in obese rats. J Lipid Res. 54(5): p. 1430-1438. DOI |
36 | Srinivasan K, et al. Combination of high-fat diet-fed and low-dose streptozotocin- treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol Res 2005;52(4):313-20. DOI |
37 | Jialal I, Amess W, Kaur M. Management of hypertriglyceridemia in the diabetic patient. Curr Diab Rep 2010;10(4):316-20. DOI |
38 | Tomlinson JW, et al. Impaired glucose tolerance and insulin resistance are associated with increased adipose 11beta-hydroxysteroid dehydrogenase type 1 expression and elevated hepatic 5alpha-reductase activity. Diabetes 2008;57(10):2652-60. DOI |
![]() |